M1 Kliniken AG

M1 Kliniken AG has a market capitalization of EUR 356.79 million, with a current market price of EUR 19.00 per share. The company has 18.78 million shares outstanding, with no dilution from diluted shares. Analysts have assigned a mean price target of EUR 27.50, indicating a potential upside of 44.7% from the current price. The company's revenue for the latest period is EUR 84.70 million. While profitability metrics such as ROIC, EBITDA margins, and net profit margins are not available, the company's revenue scale is relatively modest compared to industry peers. Analysts have not provided a consensus on the company's profitability relative to the industry median, but the absence of balance-sheet data limits a full assessment of capital efficiency. M1 Kliniken AG's revenue is not segmented by geographic region or business line in the available data. This lack of segmentation makes it difficult to assess the company's exposure to regional economic conditions or the performance of specific service lines. The company's operations are likely concentrated in Germany, given the ticker's .DE listing, but no specific geographic breakdown is available. The company's growth trajectory is not clearly defined in the available data. Analysts have not provided forward-looking revenue growth estimates, and the absence of historical revenue data prevents a year-over-year comparison. The mean recommendation of 1.33 suggests a generally positive outlook, with two strong-buy and one buy rating, but the lack of quantitative growth guidance limits the ability to assess the company's long-term potential. The risk assessment indicates a low dilution risk, with no near-term pressure from share issuance or capital-raising activities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. This lack of financial transparency increases the uncertainty around the company's short-term financial health. Recent events and filings are not detailed in the available data. The company's financial snapshot does not include any recent earnings reports, management guidance, or material events that could impact its valuation or operations. The absence of such information limits the ability to assess the company's current strategic direction or operational performance.